Abstract：
The Consortium of Eosinophilic Gastrointestinal disease Researchers (CEGIR) and The International Gastrointestinal Eosinophil Researchers (TIGERs) organized a daylong symposium at the 2024 annual meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured new discoveries in basic and translational research as well as debates on the mechanisms and management of eosinophilic gastrointestinal diseases. Updates on recent clinical trials and consensus guidelines were also presented. We summarize the updates on eosinophilic gastrointestinal diseases presented at the symposium.
摘要：
嗜酸性粒细胞胃肠道疾病研究人员联盟（CEGIR）和国际胃肠道嗜酸性粒细胞研究人员（TIGERS）在2024年美国过敏学会年会上组织了为期一天的研讨会，哮喘与免疫学。研讨会在基础和转化研究以及关于嗜酸性粒细胞性胃肠道疾病（EGID）的机制和管理的辩论方面取得了新发现。还介绍了最近的临床试验和共识指南的更新。在这里，我们总结了在研讨会上介绍的有关EGID的最新情况。
